Letter to NeuroscienceActivation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms
Section snippets
Acknowledgements
This work was supported by U.S.P.H.S. grants MH40899 and DA10044 and by the Swedish Medical Research Council (project 11580).
References (17)
- et al.
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
Trends Neurosci.
(1997) - et al.
Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptor in rat striatum
Molec. Brain Res.
(1992) - et al.
Striatal interneurones: chemical, physiological and morphological characterization
Trends Neurosci.
(1995) - et al.
Mammalian brain phosphoproteins as substrates for calcineurin
J. biol. Chem.
(1984) - et al.
Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate–putamen
Neuroscience
(1997) - et al.
Cellular expression of adenosine A2A receptors messenger RNA in the rat central nervous system with special reference to dopamine innervated areas
Neuroscience
(1997) - et al.
Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons
Neuroscience
(1998) - et al.
Inhibition by dopamine of (Na+ + K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism
Nature
(1990)
Cited by (64)
Balance between dopamine and adenosine signals regulates the PKA/Rap1 pathway in striatal medium spiny neurons
2019, Neurochemistry InternationalCitation Excerpt :The CGS21680-stimulated phosphorylation of Rap1gap at S563 was completely blocked by pretreatment with quinpirole, whereas quinpirole itself had no effect on Rap1gap phosphorylation (p < 0.01, Fig. 2a). We also confirmed the PKA activity using other well-known PKA substrates, including DARPP-32 (Lindskog et al., 1999; Yabuuchi et al., 2006), AMPA receptor GluR1 subunit (Snyder et al., 2000), and NMDA receptor NR1 subunit (Tingley et al., 1997). Treatment of the slices with CGS21680 increased phosphorylation levels of DARPP-32 at T34 (p < 0.01, Fig. 2b), AMPA receptor GluR1 subunit at S845 (p < 0.01, Fig. 2c), and NMDA receptor NR1 subunit at S897 (p < 0.01, Fig. 2d).
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia
2018, NeuropharmacologyCitation Excerpt :According to the classical theory and supported by computational modeling (Moustafa et al., 2008), the parkinsonian “off” state is explained by an imbalance between the direct and indirect pathways: the indirect pathway becomes hyperactive while the direct pathway becomes underactive. The segregated expression of PPE-A and PPE-B mRNAs as well as differential expression of μ- and δ-opioid receptors by MSNs in the two respective pathways (Lindskog et al., 1999; Noble and Cox, 2002) suggest that enkephalins modulate neurotransmission in the indirect pathway while dynorphins modulate neurotransmission in the direct pathway. The exact role of the neuropeptides in controlling the activity of the basal ganglia circuitry is less clear, though it is evident that there are important alterations in the peptidergic systems that occur in the setting of PD.
Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment
2013, European Journal of PharmacologyCitation Excerpt :In particular, DARPP-32 may be phosphorylated by dopamine D1 receptors stimulation, through the activation of PKA, thereby leading to a potent inhibition of the protein phosphatase 1 (PP-1), with the final effect of enhancing excitatory glutamatergic neurotransmission and reducing inhibitory GABA signaling in dopamine-responsive neurons (Flores-Hernandez et al., 2000, 2002; Snyder et al., 1998; Svenningsson et al., 2000). Opposite effects on DARPP-32 phosphorylation are mediated by dopamine D2 receptors (Lindskog et al., 1999). Noteworthy, the activation of serotonin 5HT2 or 5HT4/6 receptors may also increase DARPP-32 phosphorylation status (Svenningsson et al., 2002a).
Nicotinic acetylcholine receptors and the ascending dopamine pathways
2009, Biochemical Pharmacology